Association between antibody titers and protection against influenza virus infection within households

Journal of Infectious Diseases

Volumn 210, Issue 5, 2014, Pages 684-692

  Tsang, Tim K ^a   Cauchemez, Simon ^b   Perera, Ranawaka A P M ^a,c   Freeman, Guy ^a   Fang, Vicky J ^a   Ip, Dennis K M ^a   Leung, Gabriel M ^a   Malik Peiris, Joseph Sriyal ^a,c   Cowling, Benjamin J ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b INSTITUT PASTEUR   (France)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Antibody; Immunity; Influenza; Transmission

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG EFFICACY; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HOUSEHOLD; HUMAN; INFECTION PREVENTION; INFECTION RISK; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SECONDARY INFECTION; VIRUS NEUTRALIZATION; VIRUS TRANSMISSION;

ANTIBODY; IMMUNITY; INFLUENZA; TRANSMISSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; FAMILY CHARACTERISTICS; FAMILY HEALTH; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFANT; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; ORTHOMYXOVIRIDAE; POLYMERASE CHAIN REACTION; RNA, VIRAL; YOUNG ADULT;

EID: 84907423861     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu186     Document Type: Article

References (36)

1. Hobson D, Curry RL, Beare AS, Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 1972; 70:767-77.
2. Fox JP, Cooney MK, Hall CE, Foy HM. Influenzavirus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness. Am J Epidemiol 1982; 116: 228-42.
3. Coudeville L, Bailleux F, Riche B, et al. Relationship between haemagglutination- inhibiting antibody titres and clinical protection against influenza: development and application of a Bayesian random-effects model. BMC Med Res Methodol 2010; 10:18.
4. Ng S, Fang VJ, Ip DK, et al. Estimation of the association between antibody titers and protection against confirmed influenza virus infection in children. J Infect Dis 2013; 208:1320-4.
5. Cox RJ. Correlates of protection to influenza virus, where do we go from here? Hum Vaccin Immunother 2013; 9:405-8.
6. Brown F, Haaheim LR, Wood JM, Schild GC. Laboratory Correlates of Immunity to Influenza-A Reassessment. New York: S Karger Pub, 2003.
7. Veguilla V, Hancock K, Schiffer J, et al. Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations. J Clin Microbiol 2011; 49:2210-5.
8. Zhu H, Ding X, Chen X, et al. Neutralizing antibody but not hemagglutination antibody provides accurate evaluation for protective immune response to H5N1 avian influenza virus in vaccinated rabbits. Vaccine 2011; 29:5421-3.
9. Chan KH, To KK, Hung IF, et al. Differences in antibody responses of individuals with natural infection and those vaccinated against pandemic H1N1 2009 influenza. Clin Vaccine Immunol 2011; 18:867-73.
10. Cowling BJ, Chan KH, Fang VJ, et al. Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med 2010; 362:2175-84.
11. Cowling BJ, Chan KH, Fang VJ, et al. Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial. Ann Intern Med 2009; 151:437-46.
12. Lau LL, Cowling BJ, Fang VJ, et al. Viral shedding and clinical illness in naturally acquired influenza virus infections. J Infect Dis 2010; 201:1509-16.
13. Cauchemez S, Donnelly CA, Reed C, et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med 2009; 361:2619-27.
14. Cauchemez S, Carrat F, Viboud C, Valleron AJ, Boelle PY. A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data. Stat Med 2004; 23:3469-87.
15. Wu P, Cowling BJ, Wu JT, et al. The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong. Influenza Other Respir Viruses 2013; 7:367-82.
16. Wu P, Goldstein E, Ho LM, et al. Excess mortality associated with influenza A and B virus in Hong Kong, 1998-2009. J Infect Dis 2012; 206:1862-71.
17. Wu P, Goldstein E, Ho L-M, et al. Excess mortality impact of two epidemics of pandemic influenza A(H1N1pdm09) virus in Hong Kong. Influenza Other Respir Viruses 2014; 8(1):1-7.
18. Gilks WR, Richardson S, Spiegelhalter D. Markov chain Monte Carlo in practice. London: Chapman & Hall, 1996.
19. Dunning AJ. A model for immunological correlates of protection. Stat Med 2006; 25:1485-97.
20. Black S, Nicolay U, Vesikari T, Knuf M, Del Giudice G, et al. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr Infect Dis J 2011; 30:1081-5.
21. David J, Spiegelhalter NGB, Bradley P. Carlin and Angelika van der Linde Bayesian measures of model complexity and fit. J R Stat Soc 2002; 64:583-639.
22. Foy HM, Cooney MK, Allan I. Longitudinal studies of types A and B influenza among Seattle schoolchildren and families, 1968-74. J Infect Dis 1976; 134:362-9.
23. Fox JP, Hall CE, Cooney MK, Foy HM. Influenzavirus infections in Seattle families, 1975-1979. I. Study design, methods and the occurrence of infections by time and age. Am J Epidemiol 1982; 116:212-27.
24. Longini IM Jr., Koopman JS, Monto AS, Fox JP. Estimating household and community transmission parameters for influenza. Am J Epidemiol 1982; 115:736-51.
25. Ohmit SE, Thompson MG, Petrie JG, et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 2014; 58(3):319-27.
26. Stephenson I, Heath A, Major D, et al. Reproducibility of serologic assays for influenza virus A (H5N1). Emerg Infect Dis 2009; 15:1252-9.
27. Okuno Y, Tanaka K, Baba K, et al. Rapid focus reduction neutralization test of influenza A and B viruses in microtiter system. J Clin Microbiol 1990; 28:1308-13.
28. Mossong J, Hens N, Jit M, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLOS Med 2008; 5:e74.
29. Petrie JG, Ohmit SE, Cowling BJ, et al. Influenza transmission in a cohort of households with children: 2010-2011. PLOS One 2013; 8:e75339.
30. Levy JW, Cowling BJ, Simmerman JM, et al. The serial intervals of seasonal and pandemic influenza viruses in households in Bangkok, Thailand. Am J Epidemiol 2013; 177:1443-51.
31. Cowling BJ, Fang VJ, Riley S, Malik Peiris JS, Leung GM. Estimation of the serial interval of influenza. Epidemiology 2009; 20:344-7.
32. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:36-44.
33. Pebody R, Andrews N, McMenamin J, et al. Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratoryconfirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection. Euro Surveill 2013; 18:25-32.
34. Kissling E, Valenciano M, Larrauri A, et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre casecontrol study. Euro Surveill 2013; 18:2-6.
35. Cowling BJ, Ng S, Ma ES, et al. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clin Infect Dis 2010; 51:1370-9.
36. Cheng CK, Cowling BJ, Chan KH, et al. Factors affecting QuickVue Influenza A + B rapid test performance in the community setting. Diagn Microbiol Infect Dis 2009; 65:35-41. Diseases